Identification of protein targets underlying dietary nitrate-induced protection against doxorubicin cardiotoxicity.
We recently demonstrated protective effect of chronic oral nitrate supplementation against cardiomyopathy caused by doxorubicin (DOX), a highly effective anticancer drug. The present study was designed to identify novel protein targets related to nitrate-induced cardioprotection. Adult male CF-1 mice received cardioprotective regimen of nitrate (1 g NaNO(3) per litre of drinking water) for 7 days before DOX injection (15 mg/kg, i.p.) and continued for 5 days after DOX treatment. Subsequently the heart samples were collected for proteomic analysis with two-dimensional differential in-gel electrophoresis with 3 CyDye labelling. Using 1.5 cut-off ratio, we identified 36 proteins that were up-regulated by DOX in which 32 were completely reversed by nitrate supplementation (89%). Among 19 proteins down-regulated by DOX, 9 were fully normalized by nitrate (47%). The protein spots were further identified with Matrix Assisted Laser Desorption/Ionization-Time-of-Flight (MALDI-TOF)/TOF tandem mass spectrometry. Three mitochondrial antioxidant enzymes were altered by DOX, i.e. up-regulation of manganese superoxide dismutase and peroxiredoxin 3 (Prx3), and down-regulation of Prx5, which were reversed by nitrate. These results were further confirmed by Western blots. Nitrate supplementation also significantly improved animal survival rate from 80% in DOX alone group to 93% in Nitrate + DOX group 5 days after the DOX treatment. In conclusion, the proteomic analysis has identified novel protein targets underlying nitrate-induced cardioprotection. Up-regulation of Prx5 by nitrate may explain the observed enhancement of cardiac antioxidant defence by nitrate supplementation.
VCU Pauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298–0204, USA. lxi@vcu.edu
Lei
L
Xi
Shu-Guang
SG
Zhu
Daniel C
DC
Hobbs
Rakesh C
RC
Kukreja
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects / Q000633:toxicity; D000975:Antioxidants; D009202:Cardiomyopathies / Q000139:chemically induced / Q000401:mortality / Q000517:prevention & control*; D002316:Cardiotonic Agents; D054715:Cardiotoxins / Q000633:toxicity*; D004317:Doxorubicin / Q000633:toxicity*; D006321:Heart / Q000187:drug effects*; D008297:Male; D051379:Mice; D032383:Myocytes, Cardiac / Q000187:drug effects / Q000378:metabolism; D009566:Nitrates / Q000008:administration & dosage*; D009569:Nitric Oxide / Q000378:metabolism*; D018384:Oxidative Stress / Q000187:drug effects; D061105:Peroxiredoxin III / Q000096:biosynthesis; D054464:Peroxiredoxins / Q000096:biosynthesis; D040901:Proteomics; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; D013482:Superoxide Dismutase / Q000096:biosynthesis; D013534:Survival
D000903:Antibiotics, Antineoplastic; D000975:Antioxidants; D002316:Cardiotonic Agents; D054715:Cardiotoxins; D009566:Nitrates; D009569:Nitric Oxide; D004317:Doxorubicin; D061105:Peroxiredoxin III; D054464:Peroxiredoxins; D013482:Superoxide Dismutase
Biochem Biophys Res Commun. 2008 Aug 8;372(4):553-8
18503758
J Clin Invest. 2005 May;115(5):1232-40
15841216
J Pharmacol Exp Ther. 2010 Sep 1;334(3):1023-30
20543097
Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13683-8
15347817
FEBS Lett. 2005 Apr 25;579(11):2327-33
15848167
Free Radic Biol Med. 2010 Jan 15;48(2):342-7
19913611
Am J Physiol Heart Circ Physiol. 2005 May;288(5):H2163-70
15626692
Trends Mol Med. 2005 Dec;11(12):571-8
16290020
Cancer Chemother Pharmacol. 2010 Jul;66(2):303-14
19915844
J Cardiovasc Pharmacol. 1999 Nov;34(5):711-7
10547088
Arch Biochem Biophys. 1999 Feb 1;362(1):59-66
9917329
Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):19144-9
18025468
J Pharmacol Exp Ther. 2005 Dec;315(3):1314-9
16144979
Free Radic Biol Med. 2005 Jun 15;38(12):1543-52
15917183
Circulation. 1999 Apr 27;99(16):2157-63
10217657
Arch Biochem Biophys. 2007 Nov 1;467(1):95-106
17892856
Am J Clin Nutr. 2009 Jul;90(1):1-10
19439460
J Appl Physiol (1985). 2009 Oct;107(4):1144-55
19661447
Br J Nutr. 1999 May;81(5):349-58
10615207
Clin Exp Pharmacol Physiol. 1998 Jul-Aug;25(7-8):496-502
9673419
Free Radic Biol Med. 2006 Nov 1;41(9):1470-7
17023274
Hypertension. 2010 Aug;56(2):274-81
20585108
Med Pediatr Oncol. 1995 Jun;24(6):352-61
7715541
Am J Physiol Heart Circ Physiol. 2006 Mar;290(3):H1098-102
16243910
Proc Natl Acad Sci U S A. 1990 Jun;87(11):4275-9
2349236
Nat Med. 2003 Dec;9(12):1498-505
14595407
J Mol Cell Cardiol. 2001 Nov;33(11):1897-918
11708836
Am J Physiol Heart Circ Physiol. 2010 Jun;298(6):H1832-41
20363884
Int J Occup Environ Health. 1997 Jan;3(1):20-29
9891097
N Engl J Med. 1998 Sep 24;339(13):900-5
9744975
Biochem Pharmacol. 2010 Aug 15;80(4):540-7
20457137
Free Radic Biol Med. 2003 Apr 1;34(7):862-72
12654475
Am J Physiol Heart Circ Physiol. 2006 Dec;291(6):H2680-91
16782845
Proc Natl Acad Sci U S A. 2010 Oct 12;107(41):17716-20
20876122
Anal Bioanal Chem. 2005 Jun;382(3):669-78
15900442
Free Radic Biol Med. 2009 Sep 15;47(6):794-802
19540914
Cardiovasc Res. 2010 Sep 1;87(4):628-35
20489058
J Clin Invest. 1996 Sep 1;98(5):1253-60
8787689
Ann Intern Med. 1978 Feb;88(2):168-75
626445